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Abstract
Purpose There is little research-based documentation on the
services provided by drug information centres (DICs). The
aim of this multi-centre study was to explore for the first time
the factors associated with time consumption when answering
drug-related queries at eight different but comparable DICs.
Methods During an 8-week period, staff members at eight
Scandinavian DICs recorded the number of minutes during
which they responded to queries. Mixed model linear regres-
sion analyses were used to explore the factors associated with
time consumption when answering queries.
Results The mean time consumption per query was
178 min (range 4–2540 min). The mean time consumed
per query increased by 28 (95 % confidence interval (CI)
23 to 33, p<0.001) min higher for queries for which
there was a lack of documentation and 139 (95 % CI
74 to 203, p<0.001) min higher when conflicting infor-
mation was present in the literature. Staff members with
less than 1 year of experience consumed a mean of 91
more minutes (95 % CI 32 to 150, p=0.003) per query
than staff members with more than 2 years of
experience.
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Conclusions This study demonstrates the large variation in
time consumed answering queries posed to Scandinavian
DICs. The results highlight the need for highly competent
staff members and easy access to drug information sources.
Further studies are required to explore the association between
time consumption and response quality.
Keywords Drug information services . Clinical
pharmacology . Time factors . Resource allocations
Introduction
Globally, drug information centres (DICs) vary with regard to
affiliation (pharmacies, universities, university hospitals),
staff competence (pharmacists and/or physicians) and
working methods (i.e. providing solely factual drug informa-
tion or providing clinical decision support) [1–6]. Within
Scandinavia, DICs are relatively similar: they are regional
DICs staffed by pharmacists and clinical pharmacologists
who cooperate to answer queries from healthcare profes-
sionals [2–4]. The Scandinavian DICs share important fea-
tures [2–4, 7–14]. They are, to varying degrees, affiliated with
clinical pharmacology departments at university hospitals.
The centres are funded by the public healthcare system in
their respective countries, and their information is independent
of commercial interests. Queries to Scandinavian DICs are
typically patient related and concern adverse effects, drug
interactions, drug use during pregnancy or breast-feeding
and drug choice recommendations. The majority of queries
are posed by physicians, and decision support is frequently
requested [2–4]. DICs provide a valuable service by evaluat-
ing and compiling literature sources related to specific clinical
situations [4]. The working process of these centres has been
described previously [2–4].
The processes involved in providing an answer to a drug-
related query are time consuming. The majority of scientific
literature is available on the Internet, but knowing where and
how to search, how to interpret and critically evaluate litera-
ture and how to extract essential information related to a
particular clinical case require considerable knowledge and
practical training. There are few research-based data on the
factors associated with time consumed answering queries
submitted to DICs. Lyrvall et al. studied time consumed
answering queries at one Swedish DIC. Of the 100 randomly
selected queries from 1989, the time was registered for 98
queries. The mean time consumption was 187 min, whereas
the median was 128 min (range 19–1240 min) [15]. Based on
data from a pharmacist-manned DIC in the USA, Timpe et al.
reported that complex queries, i.e. those that require evalua-
tion of primary literature and critical thinking skills, were
answered within a longer time frame (mean 2.37 h) than
simple queries, i.e. queries for which no such evaluation or
critical thinking skills are necessary (mean 0.38 h) [16].
In a preliminary study of Norwegian DICs [14], we aimed
to develop a model describing the factors associated with time
consumed answering queries. The type of literature search
performed (none, simple - search in monographs, databases,
summary of product characteristics (SPCs) etc., advanced -
search in databases such as Medline to identify original
articles)and queries considered judgmental (queries that re-
quire the integration of data or knowledge and experience in
the process of making a decision regarding a specific problem
[17]) were significantly associated with time consumption,
whereas the number of drugs involved had no effect [14].
The model we developed did not describe all factors that may
affect time consumed addressing queries, as there are likely
numerous additional factors that affect time related to the
query itself and the manner in which it is handled. In addition,
our previous study was small and limited to Norwegian DICs.
The present study was conducted to describe time consump-
tion when answering drug-related queries to Scandinavian
DICs and to identify factors affecting this variable.
Material and methods
Settings and study population
In the autumn of 2012, we contacted 11 Scandinavian DICs
and presented the protocol for this study. Eight centres (four
Norwegian, three Danish and one Swedish centre) chose to
participate. The primary reason for not participating was lack
of resources. Each of the 66 staff members answering queries
during the study was provided a unique identifier that was
employed throughout the study period. The registration of the
personal data provided by individual staff members was re-
ported to the Norwegian Social Science Data Services in
accordance with national legislation.
Data collection
The study took place during the 8-week period between
January 14 and March 10, 2013. Of the 769 incoming queries
during this period, 718 (93 %) were included in the study. For
the remaining 51 queries, data were not reported for 37, and
14 were excluded because they were not posed by healthcare
professionals. The study period length was chosen based on
the normal query volume at the centres during such a time
period. The registered variables are shown in the Electronic
supplementary material, Table 1. During the study, staff mem-
bers registered the number of minutes consumed on each
query, specified in five sub-categories of tasks. Time spent
by colleagues involved in preparing the response was also
included.
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Table 1 Results of univariate
mixed model analyses exploring
factors associated with time con-
sumption when answering queries
at eight Scandinavian DICs
For each cell, the upper row rep-
resents the number of minutes
spent answering a query in the
reference category (marked Ref.
in the column for p values). The
consecutive values in the total
time column are the change in
time. These are marked + if the
time in the category exceeds the
time in the reference category and
− if the time is shorter than in the
reference category
Independent variables Number
of cases
Estimated mean
total time (min)
95 % CI
(min)
p value
Variables concerning the query
Number of drugs involved 664
One drug involved 197 112 to 281 Ref.
Extra time consumed per extra drug involved +8 3 to 14 0.005
Number of sources searched 717
No sources searched 68 8 to 128 Ref.
Extra time consumed per source searched +28 23 to 33 <0.001
Variables concerning staff members
Number of years of experience at the DIC 674
>2 years 158 78 to 239 Ref.
0–1 year +91 32 to 150 0.003
1–2 years +37 −38 to 112 0.33
Gender 675
Female 243 138 to 347 Ref.
Male −31 −89 to 27 0.29
Profession 660
Pharmacist 194 106 to 283 Ref.
Physician +16 −46 to 77 0.61
Academic qualifications 674
No PhD 200 113 to 286 Ref.
PhD +13 −53 to 79 0.69
Staff members’ judgments of the work process for the specific query
Lack of documentation 718
To a very small or small extent 183 99 to 268 Ref.
Not at all −59 −102 to −15 0.008
To some extent +73 38 to 108 <0.001
To a large or very large extent +60 24 to 97 0.001
Conflicting documentation 718
To a very small or small extent 209 125 to 294 Ref.
Not at all −58 −93 to −23 0.001
To some extent +62 23 to 100 0.002
To a large or very large extent +139 74 to 203 <0.001
Particularly complex patient case 718
To a very small or small extent 207 123 to 290 Ref.
Not at all −34 −69 to 1 0.060
To some extent +29 −11 to 70 0.16
To a large or very large extent +90 37 to 143 0.001
Heavy workload at the time 718
To a very small or small extent 220 121 to 319 Ref.
Not at all −89 −133 to −45 <0.001
To some extent +18 −19 to 54 0.34
To a large or very large extent +35 −12 to 83 0.15
Agreed response time 527
Within 1 day (same day) 97 45 to 148 Ref.
The next day +52 0 to 104 0.050
2–4 days +78 39 to 118 <0.001
5–14 days +141 104 to 179 <0.001
>14 days +159 98 to 219 <0.001
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Statistical analysis
We used a linear mixed model with the total number of
minutes registered as the dependent variable, staff members
and centres as random effects and the following as covariates:
the number of drugs involved, the number of sources
consulted, the staff member’s experience, gender and profes-
sion, lack of documentation, presence of conflicting documen-
tation, a particularly complex patient case, heavy workload at
the time and agreed response time. The analyses were per-
formed with one covariate at a time. The dependent variable
time was not normally distributed; therefore, we also per-
formed analyses using log-transformed time as the dependent
variable. These analyses yielded essentially the same results.
We report the results of the analysis of the untransformed data
which are more easily interpretable. Ninety-five percent con-
fidence intervals (CI) are provided when relevant, and two-
sided p values <0.05 were considered statistically significant.
Regarding the agreed response time, the categories unknown,
others and response time not agreed (n=191) were excluded
from the analyses. Data were analysed using SPSS 21.
Results
Of the 718 included queries, physicians posed 512 (71.3 %)
and pharmacists 120 (16.7 %), whereas others (e.g. nurses,
dentists and healthcare students) posed the remaining 86
(12.0 %). A total of 558 queries (77.7 %) concerned one or
more specific patients. The mean number of drugs involved in
the queries was 2.4 (median 1, range 1–19). Themean number
of information sources consulted per query was 4.6 (median 4,
range 0–14). No search was performed in 17 cases (2.4 %), a
simple search was performed in 327 cases (45.5 %) and an
advanced search was performed in 373 cases (51.9 %) (one
case missing). One or more recommendations were provided
in 636 cases (88.6 %). In 361 cases (56.8 %), recommenda-
tions specific to the case were provided, and in the remaining
275 cases (43.2 %), only general recommendations were
provided.
The time consumedwhen answering the 718 queries varied
from 4 to 2540 min, with a mean of 178 min. The distribution
of time consumption is shown in Fig. 1. Figure 2 depicts the
mean time consumed in each of the five categories of tasks at
each of the eight centres. The mean time consumed per query
increased by 28 min for each literature source consulted.
Table 1 shows the results of the linear regression analysis of
the association of the variables with the time consumed an-
swering queries. The mean time consumption was 60 min
higher for queries for which there was a lack of documentation
and 139 min higher when conflicting information was present
in the literature. Staff members with less than 1 year of
experience consumed a mean of 91 more minutes per query
than staff members with more than 2 years of experience
(Table 1).
The time consumption as a function of the query category
and the number of queries answered by staff members strati-
fied by their experience, gender and academic qualifications
are shown in the Electronic supplementary material, Table 2
and Table 3, respectively.
Discussion
This study showed that there is considerable variability in the
time consumed processing drug-related queries to
Scandinavian DICs. Our results are similar to results for other
European [14, 15, 18, 19] and American [16, 20] DICs. The
variability in time consumption and the skewed distribution of
data (Fig. 1) are not surprising: most queries are handled
efficiently within a few hours, but for a small number of
queries, the time consumed represents more than a full work-
ing day. These queries typically concern particularly complex
patient cases and drug treatment regimens. In addition, scien-
tific documentation may be lacking, inconclusive or conflict-
ing in the various information sources available. Table 1 illus-
trates that the complexity of queries, measured in terms of lack
of documentation, conflicting documentation and particularly
complex patient cases, is significantly associated with time
consumption.
In the present study, the number of minutes consumed
processing a response is comparable to results from Lyrvall
et al., who reported data from a Swedish DIC in 1989 [15].
Although the basic procedure for handling a drug-related
query remains the same, many changes have occurred in
25 years that may affect time consumption. In 1989, the
Internet was not used for searches, and copies of scientific
articles often had to be ordered from the library. Although
databases such as MEDLINE were available in 1989 [15], the
accessibility of the scientific literature is easier today. On the
other hand, the magnitude of available literature on a specific
subject is often considerably greater now. Furthermore, an
increase in polypharmacy and more complex drug treatment
regimens [21] may explain the lack of reduction in time
consumption despite improvements in search capability.
In the present study, the total time consumption was con-
siderably different between centres, which might reflect the
centres’ and/or staff members’ working routines. There are
some well-known differences between centres with this re-
spect, e.g. how strict their search strategies are and the mean
number of literature sources consulted. In addition, some
centres produce an English answer for a database in addition
to an answer in the native language of the enquirer, which may
require additional writing time. The differences in total time
consumption between centres might also be due to differences
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in the characteristics of the queries posed to the various
centres, although we have no evidence that such differences
in characteristics were present.
The demographic characteristics of the staff members han-
dling the queries were of minor importance to time consump-
tion, with the exception of work experience. Unsurprisingly,
more experienced staff members handled queries more swiftly
than staff members with relatively little experience. However,
within the group of subjectswithworking experience >2 years,
there was no association between experience and time con-
sumption (data not shown). Approximately half of the queries
in the present study were answered by staff members with less
than 2 years of experience (see the Electronic supplementary
material, Table 3). We have previously estimated that 3–
6 months of training are necessary to learn the basics of
addressing a query [14]. The observation that a relatively long
period of training is required, even for pharmacists and doc-
tors, to handle a query efficiently, reflects the complexity of
the work involved in producing responses to these queries.
The agreed response time significantly affected the time
consumed answering queries: the longer the agreed response
time was, the longer was the effective time consumed answer-
ing a query (Table 1). The agreed response time might reflect
the time frame within which the enquirer requires an answer,
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but might also be the result of dialogue between the enquirer
and staff member estimating how much time is required to
answer the query, e.g. based on knowledge about its complex-
ity. In addition, a response provided on the same day the query
was asked obviously cannot exceed an effective working time
of 7–8 h, thereby naturally limiting time consumption when a
rapid response is required.
Strengths and limitations
This is the first international multi-centre study exploring
factors associated with time consumed answering queries to
DICs. The participating centres are similarly organised, re-
ceive the same types of queries and use the same overall
working methods [2–4, 12–15]. We sampled a large consec-
utive cohort of queries that are reasonably representative of
the everyday working process. Although the results are pri-
marily valid for DICs in Scandinavian countries, they may
also be relevant to DICs with similar organisations and type of
queries from healthcare professionals in other countries. In
addition, the results should be of interest to the healthcare
funding authorities. The time consumed answering these
queries emphasises that researching the answers to these
queries cannot be left to enquiring healthcare professionals,
whose time is engaged in clinical practice. The answer process
requires high competence and experience in all aspects of
pharmacology among staff members, as well as training in
information search strategies and compilation of written and
verbal answers. Factors of importance for swift processing
and high quality of a response include easy access to drug
literature and systems for ensuring efficiency, e.g. documen-
tation of previous responses, cooperation between centres and
quality assurance systems.
Factors that were unaccounted for in this study may affect
the time consumed working with queries. For example, this
study did not measure patient-specific factors complicating
the queries and the personal interests and knowledge of staff
members on specific topics. The work situation may also be
affected by other working tasks, disruptions and stress. Staff
members were asked to express to what degree they felt they
had a heavy workload at the time of the query, but workload
did not significantly affect time consumption (Table 1).
We observed no differences between men and women,
pharmacists and physicians or staff members with and without
a PhD, but we observed differences in the length of DIC work
experience. Although these results appear plausible, queries
were not randomly assigned to staff members, and we cannot
ensure that a non-random query distribution did not bias the
results. For example, more complex queries may be assigned
to staff members with a PhD. In addition, due to the
open nature of the study, all staff members were aware
of their participation, which might have affected the
outcome parameters.
Conclusions
This study demonstrates a large variation in the time con-
sumed responding to drug-related queries to Scandinavian
DICs and highlights the nature and complexity of the DIC
services. The number of sources searched and the availability
and conformity of the literature appear to be principal deter-
minants of time consumption. These findings indicate the
need for highly competent staff members and easy access to
drug information sources at DICs. However, whether time
consumption affects answer quality remains unknown.
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